Home NDC 66992-425 Conjupri
Product NDC 66992-425
11-digit product format 669920425
Labeler code 66992
Product ID 66992-425_de229406-ef83-70e5-e053-2995a90ae939
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name levamlodipine
Dosage form TABLET
Route ORAL
Labeler WraSer LLC
Application NDA212895
Marketing category NDA
Marketing start 2021-08-15
Marketing end 0000-00-00
Substance LEVAMLODIPINE MALEATE
Active strength 3 mg/1
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 30 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 66992-425-30 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 66992-425-30 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 66992-425-30 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 66992-425-30 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 66992-425-30 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 66992-425-30 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 66992-425-30 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 66992-425-30 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 66992-425-30 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 66992-425-30 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 66992-425-30 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 66992-425-30 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 66992-425-30 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 66992-425-30 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 66992-425-30 1332a3947898…d4bfe170f9cd…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N212895-001 CONJUPRI LEVAMLODIPINE MALEATE EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 N212895-002 CONJUPRI LEVAMLODIPINE MALEATE EQ 2.5MG BASE TABLET / ORAL RLD 2019-12-19 N212895-003 CONJUPRI LEVAMLODIPINE MALEATE EQ 5MG BASE TABLET / ORAL RLD 2019-12-19
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 111 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N212895-001 CONJUPRI EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212895-002 CONJUPRI EQ 2.5MG BASE TABLET / ORAL RLD 2019-12-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212895-003 CONJUPRI EQ 5MG BASE TABLET / ORAL RLD 2019-12-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212895-001 CONJUPRI EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212895-002 CONJUPRI EQ 2.5MG BASE TABLET / ORAL RLD 2019-12-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212895-003 CONJUPRI EQ 5MG BASE TABLET / ORAL RLD 2019-12-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N212895-001 CONJUPRI EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212895-002 CONJUPRI EQ 2.5MG BASE TABLET / ORAL RLD 2019-12-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212895-003 CONJUPRI EQ 5MG BASE TABLET / ORAL RLD 2019-12-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212895-001 CONJUPRI EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212895-002 CONJUPRI EQ 2.5MG BASE TABLET / ORAL RLD 2019-12-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212895-003 CONJUPRI EQ 5MG BASE TABLET / ORAL RLD 2019-12-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212895-001 CONJUPRI EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212895-002 CONJUPRI EQ 2.5MG BASE TABLET / ORAL RLD 2019-12-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212895-003 CONJUPRI EQ 5MG BASE TABLET / ORAL RLD 2019-12-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212895-001 CONJUPRI EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212895-002 CONJUPRI EQ 2.5MG BASE TABLET / ORAL RLD 2019-12-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212895-003 CONJUPRI EQ 5MG BASE TABLET / ORAL RLD 2019-12-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N212895-001 CONJUPRI EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N212895-002 CONJUPRI EQ 2.5MG BASE TABLET / ORAL RLD 2019-12-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N212895-003 CONJUPRI EQ 5MG BASE TABLET / ORAL RLD 2019-12-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N212895-001 CONJUPRI EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N212895-002 CONJUPRI EQ 2.5MG BASE TABLET / ORAL RLD 2019-12-19 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N212895-003 CONJUPRI EQ 5MG BASE TABLET / ORAL RLD, RS 2019-12-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N212895-001 CONJUPRI EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N212895-002 CONJUPRI EQ 2.5MG BASE TABLET / ORAL RLD 2019-12-19 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N212895-003 CONJUPRI EQ 5MG BASE TABLET / ORAL RLD 2019-12-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N212895-001 CONJUPRI EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N212895-002 CONJUPRI EQ 2.5MG BASE TABLET / ORAL RLD 2019-12-19 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N212895-003 CONJUPRI EQ 5MG BASE TABLET / ORAL RLD 2019-12-19 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N212895-001 CONJUPRI EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N212895-002 CONJUPRI EQ 2.5MG BASE TABLET / ORAL RLD 2019-12-19 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N212895-003 CONJUPRI EQ 5MG BASE TABLET / ORAL RLD, RS 2019-12-19 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N212895-001 CONJUPRI EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N212895-002 CONJUPRI EQ 2.5MG BASE TABLET / ORAL RLD 2019-12-19 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N212895-003 CONJUPRI EQ 5MG BASE TABLET / ORAL RLD, RS 2019-12-19 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N212895-001 CONJUPRI EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N212895-002 CONJUPRI EQ 2.5MG BASE TABLET / ORAL RLD 2019-12-19 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N212895-003 CONJUPRI EQ 5MG BASE TABLET / ORAL RLD, RS 2019-12-19 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N212895-001 CONJUPRI EQ 1.25MG BASE TABLET / ORAL RLD 2019-12-19 8072bd15b7f6…
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 66992-425-30 Conjupri 30 in 1 BOTTLE TABLET 30 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 66992-425 CONJUPRI (LEVAMLODIPINE) TABLET [WRASER LLC] 2 Legacy NDC, 1 package rows 20220504_f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Conjupri LEVAMLODIPINE CSPC Ouyi Pharmaceutical Co. Ltd c3cca66e-348a-43e8-8f96-e995104dae3d 2024-12-11 Warnings, Adverse reactions Exact identifier application applno (NDA): 212895 application number: NDA212895
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 66992-425-30 66992042530 30 TABLET in 1 BOTTLE (66992-425-30) 30 tablet 2021-08-15 0000-00-00 No No Current